Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

Elevidys

Drug Genetic Disease

NDC 60923-501-10

Open in the dashboard

General payments

$1,056,794

1,377 payments

Research payments

$0

0 payments

Through program year 2025, $1,056,794 in general payments and $0 in research payments were reported against Elevidys (Genetic Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $678,812 691
2024 General $375,623 586
2023 General $2,358 100

Breakdown

Who paid General payments · program years 2023–2025
  1. Sarepta Therapeutics, Inc. $1,056,794 1,377 payments
Top recipients General payments · program year 2025
  1. Erika Finanger Neurology with Special Qualifications in Child Neurology · Portland, OR $26,007 4% · 18 payments
  2. Omer Abdul Hamid Neurology with Special Qualifications in Child Neurology · Orlando, FL $25,965 4% · 28 payments
  3. Sarah Wright Neurology with Special Qualifications in Child Neurology · Washington, DC $23,214 3% · 20 payments
  4. Daniel Guillen Mendoza Neuromuscular Medicine · Memphis, TN $18,162 3% · 20 payments
  5. Perry Shieh Neurology · Los Angeles, CA $17,670 3% · 15 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $406,005 60% · 61 practitioners
  2. Neuromuscular Medicine Psychiatry & Neurology $71,403 11% · 8 practitioners
  3. Neurology Psychiatry & Neurology $59,304 9% · 7 practitioners
  4. Physical Medicine & Rehabilitation $29,639 4% · 5 practitioners
  5. Pediatric Cardiology Pediatrics $21,105 3% · 3 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $76,659 11% · 17 recipients
  2. Pennsylvania $67,764 10% · 8 recipients
  3. Florida $62,129 9% · 9 recipients
  4. Ohio $58,334 9% · 7 recipients
  5. Texas $47,326 7% · 14 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

1,377 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record